Giant cell arteritis: controversial issues

Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vnitřní lékar̆stvĭ 2021-07, Vol.67 (4), p.224-229
1. Verfasser: Alušík, Štefan
Format: Artikel
Sprache:cze ; eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 229
container_issue 4
container_start_page 224
container_title Vnitřní lékar̆stvĭ
container_volume 67
creator Alušík, Štefan
description Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment.
doi_str_mv 10.36290/vnl.2021.057
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2553246400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2553246400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c948-f0268c1974cdaa91f41adafc7904cd1499b531a20d5ff12b50dc5b06f60dd4e43</originalsourceid><addsrcrecordid>eNo9kE1LAzEQhoMottQevcoeRdg6-d54E9EqFLz04C1k8wGR7W5NtgX_vamtzuWF4eGd4UHoGsOCCqLgft93CwIEL4DLMzTFDeBackXO0RSAkVpK-jFB85w_oYxQgku4RBPKiOQUmim6W0bTj5X1XVeZNPoUx5gfKjv0Yxr2PuVouirmvPP5Cl0E02U_P-UMrV-e10-v9ep9-fb0uKqtYk0dgIjGYiWZdcYoHBg2zgQrFZQNZkq1nGJDwPEQMGk5OMtbEEGAc8wzOkO3x9ptGr7K2VFvYj78Z3o_7LImnFPCBAMoaH1EbRpyTj7obYobk741Bv0rSBdB-iBIF0GFvzlV79qNd__0nw76Ax--YEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2553246400</pqid></control><display><type>article</type><title>Giant cell arteritis: controversial issues</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Alušík, Štefan</creator><creatorcontrib>Alušík, Štefan</creatorcontrib><description>Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment.</description><identifier>ISSN: 0042-773X</identifier><identifier>EISSN: 1801-7592</identifier><identifier>DOI: 10.36290/vnl.2021.057</identifier><identifier>PMID: 34275308</identifier><language>cze ; eng</language><publisher>Czech Republic</publisher><subject>Biopsy ; Giant Cell Arteritis - diagnosis ; Giant Cell Arteritis - drug therapy ; Glucocorticoids - therapeutic use ; Humans ; Inflammation ; Male ; Temporal Arteries</subject><ispartof>Vnitřní lékar̆stvĭ, 2021-07, Vol.67 (4), p.224-229</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c948-f0268c1974cdaa91f41adafc7904cd1499b531a20d5ff12b50dc5b06f60dd4e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34275308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alušík, Štefan</creatorcontrib><title>Giant cell arteritis: controversial issues</title><title>Vnitřní lékar̆stvĭ</title><addtitle>Vnitr Lek</addtitle><description>Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment.</description><subject>Biopsy</subject><subject>Giant Cell Arteritis - diagnosis</subject><subject>Giant Cell Arteritis - drug therapy</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Male</subject><subject>Temporal Arteries</subject><issn>0042-773X</issn><issn>1801-7592</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LAzEQhoMottQevcoeRdg6-d54E9EqFLz04C1k8wGR7W5NtgX_vamtzuWF4eGd4UHoGsOCCqLgft93CwIEL4DLMzTFDeBackXO0RSAkVpK-jFB85w_oYxQgku4RBPKiOQUmim6W0bTj5X1XVeZNPoUx5gfKjv0Yxr2PuVouirmvPP5Cl0E02U_P-UMrV-e10-v9ep9-fb0uKqtYk0dgIjGYiWZdcYoHBg2zgQrFZQNZkq1nGJDwPEQMGk5OMtbEEGAc8wzOkO3x9ptGr7K2VFvYj78Z3o_7LImnFPCBAMoaH1EbRpyTj7obYobk741Bv0rSBdB-iBIF0GFvzlV79qNd__0nw76Ax--YEg</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Alušík, Štefan</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210701</creationdate><title>Giant cell arteritis: controversial issues</title><author>Alušík, Štefan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c948-f0268c1974cdaa91f41adafc7904cd1499b531a20d5ff12b50dc5b06f60dd4e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>cze ; eng</language><creationdate>2021</creationdate><topic>Biopsy</topic><topic>Giant Cell Arteritis - diagnosis</topic><topic>Giant Cell Arteritis - drug therapy</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Male</topic><topic>Temporal Arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alušík, Štefan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Vnitřní lékar̆stvĭ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alušík, Štefan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Giant cell arteritis: controversial issues</atitle><jtitle>Vnitřní lékar̆stvĭ</jtitle><addtitle>Vnitr Lek</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>67</volume><issue>4</issue><spage>224</spage><epage>229</epage><pages>224-229</pages><issn>0042-773X</issn><eissn>1801-7592</eissn><abstract>Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment.</abstract><cop>Czech Republic</cop><pmid>34275308</pmid><doi>10.36290/vnl.2021.057</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0042-773X
ispartof Vnitřní lékar̆stvĭ, 2021-07, Vol.67 (4), p.224-229
issn 0042-773X
1801-7592
language cze ; eng
recordid cdi_proquest_miscellaneous_2553246400
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Biopsy
Giant Cell Arteritis - diagnosis
Giant Cell Arteritis - drug therapy
Glucocorticoids - therapeutic use
Humans
Inflammation
Male
Temporal Arteries
title Giant cell arteritis: controversial issues
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A59%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Giant%20cell%20arteritis:%20controversial%20issues&rft.jtitle=Vnit%C5%99n%C3%AD%20l%C3%A9kar%CC%86stv%C4%AD&rft.au=Alu%C5%A1%C3%ADk,%20%C5%A0tefan&rft.date=2021-07-01&rft.volume=67&rft.issue=4&rft.spage=224&rft.epage=229&rft.pages=224-229&rft.issn=0042-773X&rft.eissn=1801-7592&rft_id=info:doi/10.36290/vnl.2021.057&rft_dat=%3Cproquest_cross%3E2553246400%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2553246400&rft_id=info:pmid/34275308&rfr_iscdi=true